A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.

NCT06369935 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

260

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Multiple Myeloma

Interventions

DRUG: Equecabtagene Autoleucel

Sponsor

Peking University People's Hospital